Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination
- PMID: 17764659
- DOI: 10.1016/j.bbrc.2007.08.062
Inactivation of the mouse Atxn3 (ataxin-3) gene increases protein ubiquitination
Abstract
Spinocerebellar ataxia type 3 is a neurodegenerative disease caused by expansion of a polyglutamine domain in the protein ataxin-3 (ATXN3). Physiological functions of ATXN3 presumably include ubiquitin protease and transcriptional corepressor activity. To gain insight into the function of ATXN3 and to test the hypothesis that loss of ATXN3 contributes to the pathology in SCA3 we generated Atxn3 knockout (ko) mice by targeted mutagenesis. Loss of Atxn3 did not affect viability or fertility and Atxn3 ko mice displayed no overt abnormalities. On the accelerating Rotarod Atxn3 ko mice performed as well as wildtype (wt) animals, but reduced exploratory behavior in the open field suggested a sense of heightened anxiety. While no gross deficits were apparent upon morphological examination, we found increased levels of ubiquitinated proteins in Atxn3 ko tissues. Thus Atxn3 ko mice provide the first in vivo reference to the deubiquitinating activity of ATXN3.
Similar articles
-
Comparison of spinocerebellar ataxia type 3 mouse models identifies early gain-of-function, cell-autonomous transcriptional changes in oligodendrocytes.Hum Mol Genet. 2017 Sep 1;26(17):3362-3374. doi: 10.1093/hmg/ddx224. Hum Mol Genet. 2017. PMID: 28854700 Free PMC article.
-
Absence of ataxin-3 leads to cytoskeletal disorganization and increased cell death.Biochim Biophys Acta. 2010 Oct;1803(10):1154-63. doi: 10.1016/j.bbamcr.2010.07.004. Epub 2010 Jul 15. Biochim Biophys Acta. 2010. PMID: 20637808
-
Lysine 117 on ataxin-3 modulates toxicity in Drosophila models of Spinocerebellar Ataxia Type 3.J Neurol Sci. 2023 Nov 15;454:120828. doi: 10.1016/j.jns.2023.120828. Epub 2023 Oct 5. J Neurol Sci. 2023. PMID: 37865002 Free PMC article.
-
Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways.PLoS One. 2018 Sep 19;13(9):e0204438. doi: 10.1371/journal.pone.0204438. eCollection 2018. PLoS One. 2018. PMID: 30231063 Free PMC article.
-
Progress in pathogenesis studies of spinocerebellar ataxia type 1.Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):1079-81. doi: 10.1098/rstb.1999.0462. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434309 Free PMC article. Review.
Cited by
-
Degron capability of the hydrophobic C-terminus of the polyglutamine disease protein, ataxin-3.J Neurosci Res. 2020 Oct;98(10):2096-2108. doi: 10.1002/jnr.24684. Epub 2020 Jul 9. J Neurosci Res. 2020. PMID: 32643791 Free PMC article.
-
Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias.Neurochem Res. 2011 Jul;36(7):1186-97. doi: 10.1007/s11064-010-0393-y. Epub 2011 Jan 6. Neurochem Res. 2011. PMID: 21210219 Free PMC article. Review.
-
Deficiency in classical nonhomologous end-joining-mediated repair of transcribed genes is linked to SCA3 pathogenesis.Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):8154-8165. doi: 10.1073/pnas.1917280117. Epub 2020 Mar 23. Proc Natl Acad Sci U S A. 2020. PMID: 32205441 Free PMC article.
-
Protein quality control in the endoplasmic reticulum.F1000Prime Rep. 2014 Jul 8;6:49. doi: 10.12703/P6-49. eCollection 2014. F1000Prime Rep. 2014. PMID: 25184039 Free PMC article. Review.
-
Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies.Front Mol Neurosci. 2018 May 15;11:153. doi: 10.3389/fnmol.2018.00153. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29867345 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
